ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000268564.1	ABT-263 (navitoclax)	Esophageal cancer	0.025091793	Sensitive
ENSG00000268564.1	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.022623413	Sensitive